WELLS FARGO & COMPANY/MN - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 29 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$01,060
+30.4%
0.00%
Q1 2022$0813
+0.4%
0.00%
Q4 2021$0810
+0.1%
0.00%
Q3 2021$0
-100.0%
809
-4.7%
0.00%
Q2 2021$1,0000.0%849
+1.1%
0.00%
Q1 2021$1,000840
+546.2%
0.00%
Q4 2020$0130
+9.2%
0.00%
Q3 2020$0119
+5.3%
0.00%
Q2 2020$0113
-11.0%
0.00%
Q1 2020$0127
+746.7%
0.00%
Q4 2019$015
-6.2%
0.00%
Q3 2019$016
+6.7%
0.00%
Q2 2019$0150.0%0.00%
Q1 2019$0150.0%0.00%
Q4 2018$015
+1400.0%
0.00%
Q3 2018$010.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MSD Partners, L.P. 960,680$655,0000.02%
Virtu Financial LLC 466,704$318,0000.02%
tru Independence LLC 60,000$30,0000.01%
Jacobi Capital Management LLC 18,500$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,300$75,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 576,927$393,0000.00%
Stratos Wealth Partners, LTD. 10,850$7,0000.00%
NewEdge Advisors, LLC 14,187$10,0000.00%
Sowell Financial Services LLC 74$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders